Sahlgrenska Pioneers Heat-Based Needle Treatment for Insulinoma in Sweden
Photo by Natanael Melchor on Unsplash
TL;DR: Sahlgrenska University Hospital is the first in Sweden to use heat-based endoscopic radiofrequency ablation (EUS RFA) to treat benign, insulin-producing tumors in the pancreas called insulinomas. This offers a less invasive treatment option for patients who traditionally require surgery for the rare condition which causes excessive insulin production and subsequent hypoglycemia.
Key takeaways
- Sahlgrenska University Hospital has pioneered a new treatment for benign, insulin-producing tumors in the pancreas, becoming the first institution in Sweden to perform heat-based endoscopic radiofrequency ablation (EUS RFA)
- This innovative procedure offers a less invasive alternative for managing insulinoma
- Insulinoma is a rare tumor that causes excessive insulin production, leading to recurrent hypoglycemia
Related Topics
Want coverage like this for your company?
Local & industry wins build trusted proof, SEO/geo signals and prime national editors.
Check fit (2 min)Is this your company?
Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.
Want to turn mentions into momentum? Find your best path with the Fit Checker. Verified profiles receive a free consult.